EUVIMEDAtrasti EUVIMED
CrossrefInformacijos kortelė

Bivariate Copula Models With Event‐Free Cure Effect for Survival Extrapolations and Individual‐Level Correlation Analysis

Daniel J. Sharpe, Georgia Yates, Tuli De, Renuka Kandikatla, Prianka Singh, Matthew Dixon, Kiran Davé, Jackie Vanderpuye‐Orgle, Murat Kurt

Statistics in Medicine · 2026-11 · 45 (25-27)

DOI: 10.1002/sim.70763 ↗
SantraukaBibliografiniai duomenys

Santrauka

ABSTRACT Objectives Overall survival (OS) extrapolations from mixture cure models (MCMs) are often sensitive to the cure fraction, which is challenging to estimate when data are immature. Furthermore, in some cancer populations, it may be unreasonable to assume curative effects among patients who are not event‐free. We addressed these problems using bivariate copula MCMs to jointly model OS and progression‐ (PFS) or recurrence‐free survival (RFS), with a single event‐free cure fraction parameter. Methods We proposed a practical framework for parametric survival copula model selection and interpretation, which involves estimating five representative candidate copula functions and examining OS distributions conditioned on intermediate event times. Bivariate MCMs with event‐free cure fraction, based on previously selected marginal distributions, were estimated for two studies of nivolumab with contrasting survival patterns, namely, in previously treated advanced esophageal squamous cell carcinoma (OS‐PFS correlation) and resected melanoma (OS‐RFS correlation). Results OS extrapolations from bivariate MCMs with an effective PFS (or RFS) cure fraction were more conservative than from univariate MCMs. Although patient‐level OS‐PFS/RFS correlation coefficients were sensitive to the copula, model averaging and inspecting estimated conditional OS distributions enabled clinically meaningful inference on the prognostic impact of intermediate events. Conclusions Bivariate MCMs with event‐free cured subpopulation incorporated curative effects into OS extrapolations more cautiously than conventional MCMs, based on a more rapidly maturing composite endpoint. The model is especially useful when OS data are immature and if post‐event cure is clinically implausible. Employing alternative copulas that cover archetypal association patterns mitigated model selection bias in patient‐level correlation analysis.

Jūsų darbui tinkamos žinios.

Nuo nemokamos pradžios ir asmeninės literatūros paieškos iki viso Research Suite.

Peržiūrėti tarifus →

Ar įtraukti visi leidėjų pilnieji tekstai?

Ne. Bibliografiniai įrašai, santraukos ir pilnieji tekstai yra skirtingas turinys. Ar pilnasis tekstas prieinamas, priklauso nuo šaltinio, Open Access ir jūsų turimų licencijų. EUVIMED planas nepakeičia papildomų leidėjų teisių.

Peržiūrėti tarifus →